APO Research
Talk to an analyst

APO RESEARCH · REPORT

Needle-free Hypodermic Syringe

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Needle-free Hypodermic Syringe Market Outlook and Growth Opportunities 2026

24 December 2025193 pages

Choose your research edition.

Industry ResearchNeedle-free Hypodermic Syringe Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Needle-free Hypodermic Syringe Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Needle-free Hypodermic Syringe Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Needle-free Hypodermic Syringe Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Needle-free Hypodermic Syringe Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Needle-free Hypodermic Syringe market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Needle-free Hypodermic Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Needle-free Hypodermic Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Needle-free Hypodermic Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Needle-free Hypodermic Syringe market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Needle-free Hypodermic Syringe market include Zoetis, Aptar Pharma, Veloxis Pharmaceuticals, SHL Medical, Portal Instruments, PharmaJet, PenJet, Oval Medical Technologies and Lifecare AS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Needle-free Hypodermic Syringe market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Needle-free Hypodermic Syringe and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Needle-free Hypodermic Syringe sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Needle-free Hypodermic Syringe market size, projected growth trends, production technologies, key applications, and end-use industries.

Needle-free Hypodermic Syringe Segment by Company

Zoetis

Aptar Pharma

Veloxis Pharmaceuticals

SHL Medical

Portal Instruments

PharmaJet

PenJet

Oval Medical Technologies

Lifecare AS

Enable Injections

Crossject

Antares Pharma

Needle-free Hypodermic Syringe Segment by Type

Electric Needle-Free Injector

Hydraulic Needle-Free Injector

Needle-free Hypodermic Syringe Segment by Application

Hospital

Specialist Clinic

Others

Needle-free Hypodermic Syringe Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Needle-free Hypodermic Syringe status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Needle-free Hypodermic Syringe market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Needle-free Hypodermic Syringe significant trends, drivers, influence factors in global and regions.

6. To analyze Needle-free Hypodermic Syringe competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Needle-free Hypodermic Syringe market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Needle-free Hypodermic Syringe and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Needle-free Hypodermic Syringe.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Needle-free Hypodermic Syringe market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Needle-free Hypodermic Syringe industry.

Chapter 3: Detailed analysis of Needle-free Hypodermic Syringe manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Needle-free Hypodermic Syringe in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Needle-free Hypodermic Syringe in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Needle-free Hypodermic Syringe Industry Trends Table 2. Needle-free Hypodermic Syringe Industry Drivers Table 3. Needle-free Hypodermic Syringe Industry Opportunities and Challenges Table 4. Needle-free Hypodermic Syringe Industry Restraints Table 5. Global Needle-free Hypodermic Syringe Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Needle-free Hypodermic Syringe Revenue Share by Company (2021-2026) Table 7. Global Needle-free Hypodermic Syringe Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Needle-free Hypodermic Syringe Sales Volume Share by Company (2021-2026) Table 9. Global Needle-free Hypodermic Syringe Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Needle-free Hypodermic Syringe Company Ranking, (2024-2026) & (USD Million) Table 11. Global Needle-free Hypodermic Syringe Key Company Manufacturing Base & Headquarters Table 12. Global Needle-free Hypodermic Syringe Company, Product Type & Application Table 13. Global Needle-free Hypodermic Syringe Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Needle-free Hypodermic Syringe by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Electric Needle-Free Injector Table 18. Significant Companies of Hydraulic Needle-Free Injector Table 19. Global Needle-free Hypodermic Syringe Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Needle-free Hypodermic Syringe Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Needle-free Hypodermic Syringe Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Needle-free Hypodermic Syringe Sales Volume Share by Type (2021-2026) Table 23. Global Needle-free Hypodermic Syringe Sales Volume Share by Type (2027-2032) Table 24. Global Needle-free Hypodermic Syringe Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Needle-free Hypodermic Syringe Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Needle-free Hypodermic Syringe Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Needle-free Hypodermic Syringe Sales Value Share by Type (2021-2026) Table 28. Global Needle-free Hypodermic Syringe Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Specialist Clinic Table 31. Significant Companies of Others Table 32. Global Needle-free Hypodermic Syringe Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Needle-free Hypodermic Syringe Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Needle-free Hypodermic Syringe Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Needle-free Hypodermic Syringe Sales Volume Share by Application (2021-2026) Table 36. Global Needle-free Hypodermic Syringe Sales Volume Share by Application (2027-2032) Table 37. Global Needle-free Hypodermic Syringe Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Needle-free Hypodermic Syringe Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Needle-free Hypodermic Syringe Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Needle-free Hypodermic Syringe Sales Value Share by Application (2021-2026) Table 41. Global Needle-free Hypodermic Syringe Sales Value Share by Application (2027-2032) Table 42. Global Needle-free Hypodermic Syringe Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Needle-free Hypodermic Syringe Sales by Region (2021-2026) & (K Units) Table 44. Global Needle-free Hypodermic Syringe Sales Market Share by Region (2021-2026) Table 45. Global Needle-free Hypodermic Syringe Sales by Region (2027-2032) & (K Units) Table 46. Global Needle-free Hypodermic Syringe Sales Market Share by Region (2027-2032) Table 47. Global Needle-free Hypodermic Syringe Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Needle-free Hypodermic Syringe Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Needle-free Hypodermic Syringe Sales Value Share by Region (2021-2026) Table 50. Global Needle-free Hypodermic Syringe Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Needle-free Hypodermic Syringe Sales Value Share by Region (2027-2032) Table 52. Global Needle-free Hypodermic Syringe Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Needle-free Hypodermic Syringe Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Needle-free Hypodermic Syringe Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Needle-free Hypodermic Syringe Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Needle-free Hypodermic Syringe Sales by Country (2021-2026) & (K Units) Table 57. Global Needle-free Hypodermic Syringe Sales Market Share by Country (2021-2026) Table 58. Global Needle-free Hypodermic Syringe Sales by Country (2027-2032) & (K Units) Table 59. Global Needle-free Hypodermic Syringe Sales Market Share by Country (2027-2032) Table 60. Global Needle-free Hypodermic Syringe Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Needle-free Hypodermic Syringe Sales Value Market Share by Country (2021-2026) Table 62. Global Needle-free Hypodermic Syringe Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Needle-free Hypodermic Syringe Sales Value Market Share by Country (2027-2032) Table 64. Zoetis Company Information Table 65. Zoetis Business Overview Table 66. Zoetis Needle-free Hypodermic Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Zoetis Needle-free Hypodermic Syringe Product Portfolio Table 68. Zoetis Recent Development Table 69. Aptar Pharma Company Information Table 70. Aptar Pharma Business Overview Table 71. Aptar Pharma Needle-free Hypodermic Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Aptar Pharma Needle-free Hypodermic Syringe Product Portfolio Table 73. Aptar Pharma Recent Development Table 74. Veloxis Pharmaceuticals Company Information Table 75. Veloxis Pharmaceuticals Business Overview Table 76. Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Product Portfolio Table 78. Veloxis Pharmaceuticals Recent Development Table 79. SHL Medical Company Information Table 80. SHL Medical Business Overview Table 81. SHL Medical Needle-free Hypodermic Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. SHL Medical Needle-free Hypodermic Syringe Product Portfolio Table 83. SHL Medical Recent Development Table 84. Portal Instruments Company Information Table 85. Portal Instruments Business Overview Table 86. Portal Instruments Needle-free Hypodermic Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Portal Instruments Needle-free Hypodermic Syringe Product Portfolio Table 88. Portal Instruments Recent Development Table 89. PharmaJet Company Information Table 90. PharmaJet Business Overview Table 91. PharmaJet Needle-free Hypodermic Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. PharmaJet Needle-free Hypodermic Syringe Product Portfolio Table 93. PharmaJet Recent Development Table 94. PenJet Company Information Table 95. PenJet Business Overview Table 96. PenJet Needle-free Hypodermic Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. PenJet Needle-free Hypodermic Syringe Product Portfolio Table 98. PenJet Recent Development Table 99. Oval Medical Technologies Company Information Table 100. Oval Medical Technologies Business Overview Table 101. Oval Medical Technologies Needle-free Hypodermic Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Oval Medical Technologies Needle-free Hypodermic Syringe Product Portfolio Table 103. Oval Medical Technologies Recent Development Table 104. Lifecare AS Company Information Table 105. Lifecare AS Business Overview Table 106. Lifecare AS Needle-free Hypodermic Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Lifecare AS Needle-free Hypodermic Syringe Product Portfolio Table 108. Lifecare AS Recent Development Table 109. Enable Injections Company Information Table 110. Enable Injections Business Overview Table 111. Enable Injections Needle-free Hypodermic Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Enable Injections Needle-free Hypodermic Syringe Product Portfolio Table 113. Enable Injections Recent Development Table 114. Crossject Company Information Table 115. Crossject Business Overview Table 116. Crossject Needle-free Hypodermic Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Crossject Needle-free Hypodermic Syringe Product Portfolio Table 118. Crossject Recent Development Table 119. Antares Pharma Company Information Table 120. Antares Pharma Business Overview Table 121. Antares Pharma Needle-free Hypodermic Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Antares Pharma Needle-free Hypodermic Syringe Product Portfolio Table 123. Antares Pharma Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Needle-free Hypodermic Syringe Distributors List Table 127. Needle-free Hypodermic Syringe Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Needle-free Hypodermic Syringe Product Image Figure 2. Global Needle-free Hypodermic Syringe Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Needle-free Hypodermic Syringe Sales Value (2021-2032) & (US$ Million) Figure 4. Global Needle-free Hypodermic Syringe Sales (2021-2032) & (K Units) Figure 5. Global Needle-free Hypodermic Syringe Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Needle-free Hypodermic Syringe Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Electric Needle-Free Injector Image Figure 10. Hydraulic Needle-Free Injector Image Figure 11. Global Needle-free Hypodermic Syringe Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Needle-free Hypodermic Syringe Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Needle-free Hypodermic Syringe Sales Volume Share by Type (2021-2032) Figure 14. Global Needle-free Hypodermic Syringe Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Needle-free Hypodermic Syringe Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Needle-free Hypodermic Syringe Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Specialist Clinic Image Figure 19. Others Image Figure 20. Global Needle-free Hypodermic Syringe Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Needle-free Hypodermic Syringe Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Needle-free Hypodermic Syringe Sales Volume Share by Application (2021-2032) Figure 23. Global Needle-free Hypodermic Syringe Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Needle-free Hypodermic Syringe Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Needle-free Hypodermic Syringe Sales Value Share by Application (2021-2032) Figure 26. Global Needle-free Hypodermic Syringe Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Needle-free Hypodermic Syringe Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Needle-free Hypodermic Syringe Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Needle-free Hypodermic Syringe Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Needle-free Hypodermic Syringe Sales Value (2021-2032) & (US$ Million) Figure 31. North America Needle-free Hypodermic Syringe Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Needle-free Hypodermic Syringe Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Needle-free Hypodermic Syringe Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Needle-free Hypodermic Syringe Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Needle-free Hypodermic Syringe Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Needle-free Hypodermic Syringe Sales Value (2021-2032) & (US$ Million) Figure 37. South America Needle-free Hypodermic Syringe Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Needle-free Hypodermic Syringe Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Needle-free Hypodermic Syringe Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Needle-free Hypodermic Syringe Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Needle-free Hypodermic Syringe Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Electric Needle-Free Injector
  • Hydraulic Needle-Free Injector
Applications
  • Hospital
  • Specialist Clinic
  • Others
Companies covered
  • Zoetis
  • Aptar Pharma
  • Veloxis Pharmaceuticals
  • SHL Medical
  • Portal Instruments
  • PharmaJet
  • PenJet
  • Oval Medical Technologies
  • Lifecare AS
  • Enable Injections
  • Crossject
  • Antares Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Needle-free Hypodermic Syringe Sales Value (2021-2032)
  4. 1.2.2 Global Needle-free Hypodermic Syringe Sales Volume (2021-2032)
  5. 1.2.3 Global Needle-free Hypodermic Syringe Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Needle-free Hypodermic Syringe Market Dynamics
  1. 2.1 Needle-free Hypodermic Syringe Industry Trends
  2. 2.2 Needle-free Hypodermic Syringe Industry Drivers
  3. 2.3 Needle-free Hypodermic Syringe Industry Opportunities and Challenges
  4. 2.4 Needle-free Hypodermic Syringe Industry Restraints
3 Needle-free Hypodermic Syringe Market by Company
  1. 3.1 Global Needle-free Hypodermic Syringe Company Revenue Ranking in 2025
  2. 3.2 Global Needle-free Hypodermic Syringe Revenue by Company (2021-2026)
  3. 3.3 Global Needle-free Hypodermic Syringe Sales Volume by Company (2021-2026)
  4. 3.4 Global Needle-free Hypodermic Syringe Average Price by Company (2021-2026)
  5. 3.5 Global Needle-free Hypodermic Syringe Company Ranking (2024-2026)
  6. 3.6 Global Needle-free Hypodermic Syringe Company Manufacturing Base and Headquarters
  7. 3.7 Global Needle-free Hypodermic Syringe Company Product Type and Application
  8. 3.8 Global Needle-free Hypodermic Syringe Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Needle-free Hypodermic Syringe Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Needle-free Hypodermic Syringe Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Needle-free Hypodermic Syringe Market by Type
  1. 4.1 Needle-free Hypodermic Syringe Type Introduction
  2. 4.1.1 Electric Needle-Free Injector
  3. 4.1.2 Hydraulic Needle-Free Injector
  4. 4.2 Global Needle-free Hypodermic Syringe Sales Volume by Type
  5. 4.2.1 Global Needle-free Hypodermic Syringe Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Needle-free Hypodermic Syringe Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Needle-free Hypodermic Syringe Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Needle-free Hypodermic Syringe Sales Value by Type
  9. 4.3.1 Global Needle-free Hypodermic Syringe Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Needle-free Hypodermic Syringe Sales Value by Type (2021-2032)
  11. 4.3.3 Global Needle-free Hypodermic Syringe Sales Value Share by Type (2021-2032)
5 Needle-free Hypodermic Syringe Market by Application
  1. 5.1 Needle-free Hypodermic Syringe Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Specialist Clinic
  4. 5.1.3 Others
  5. 5.2 Global Needle-free Hypodermic Syringe Sales Volume by Application
  6. 5.2.1 Global Needle-free Hypodermic Syringe Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Needle-free Hypodermic Syringe Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Needle-free Hypodermic Syringe Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Needle-free Hypodermic Syringe Sales Value by Application
  10. 5.3.1 Global Needle-free Hypodermic Syringe Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Needle-free Hypodermic Syringe Sales Value by Application (2021-2032)
  12. 5.3.3 Global Needle-free Hypodermic Syringe Sales Value Share by Application (2021-2032)
6 Needle-free Hypodermic Syringe Regional Sales and Value Analysis
  1. 6.1 Global Needle-free Hypodermic Syringe Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Needle-free Hypodermic Syringe Sales by Region (2021-2032)
  3. 6.2.1 Global Needle-free Hypodermic Syringe Sales by Region: 2021-2026
  4. 6.2.2 Global Needle-free Hypodermic Syringe Sales by Region (2027-2032)
  5. 6.3 Global Needle-free Hypodermic Syringe Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Needle-free Hypodermic Syringe Sales Value by Region (2021-2032)
  7. 6.4.1 Global Needle-free Hypodermic Syringe Sales Value by Region: 2021-2026
  8. 6.4.2 Global Needle-free Hypodermic Syringe Sales Value by Region (2027-2032)
  9. 6.5 Global Needle-free Hypodermic Syringe Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Needle-free Hypodermic Syringe Sales Value (2021-2032)
  12. 6.6.2 North America Needle-free Hypodermic Syringe Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Needle-free Hypodermic Syringe Sales Value (2021-2032)
  15. 6.7.2 Europe Needle-free Hypodermic Syringe Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Needle-free Hypodermic Syringe Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Needle-free Hypodermic Syringe Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Needle-free Hypodermic Syringe Sales Value (2021-2032)
  21. 6.9.2 South America Needle-free Hypodermic Syringe Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Needle-free Hypodermic Syringe Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Needle-free Hypodermic Syringe Sales Value Share by Country, 2025 VS 2032
7 Needle-free Hypodermic Syringe Country-level Sales and Value Analysis
  1. 7.1 Global Needle-free Hypodermic Syringe Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Needle-free Hypodermic Syringe Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Needle-free Hypodermic Syringe Sales by Country (2021-2032)
  4. 7.3.1 Global Needle-free Hypodermic Syringe Sales by Country (2021-2026)
  5. 7.3.2 Global Needle-free Hypodermic Syringe Sales by Country (2027-2032)
  6. 7.4 Global Needle-free Hypodermic Syringe Sales Value by Country (2021-2032)
  7. 7.4.1 Global Needle-free Hypodermic Syringe Sales Value by Country (2021-2026)
  8. 7.4.2 Global Needle-free Hypodermic Syringe Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Needle-free Hypodermic Syringe Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Needle-free Hypodermic Syringe Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Needle-free Hypodermic Syringe Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Needle-free Hypodermic Syringe Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Needle-free Hypodermic Syringe Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Aptar Pharma
  8. 8.2.1 Aptar Pharma Company Information
  9. 8.2.2 Aptar Pharma Business Overview
  10. 8.2.3 Aptar Pharma Needle-free Hypodermic Syringe Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Aptar Pharma Needle-free Hypodermic Syringe Product Portfolio
  12. 8.2.5 Aptar Pharma Recent Developments
  13. 8.3 Veloxis Pharmaceuticals
  14. 8.3.1 Veloxis Pharmaceuticals Company Information
  15. 8.3.2 Veloxis Pharmaceuticals Business Overview
  16. 8.3.3 Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Product Portfolio
  18. 8.3.5 Veloxis Pharmaceuticals Recent Developments
  19. 8.4 SHL Medical
  20. 8.4.1 SHL Medical Company Information
  21. 8.4.2 SHL Medical Business Overview
  22. 8.4.3 SHL Medical Needle-free Hypodermic Syringe Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 SHL Medical Needle-free Hypodermic Syringe Product Portfolio
  24. 8.4.5 SHL Medical Recent Developments
  25. 8.5 Portal Instruments
  26. 8.5.1 Portal Instruments Company Information
  27. 8.5.2 Portal Instruments Business Overview
  28. 8.5.3 Portal Instruments Needle-free Hypodermic Syringe Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Portal Instruments Needle-free Hypodermic Syringe Product Portfolio
  30. 8.5.5 Portal Instruments Recent Developments
  31. 8.6 PharmaJet
  32. 8.6.1 PharmaJet Company Information
  33. 8.6.2 PharmaJet Business Overview
  34. 8.6.3 PharmaJet Needle-free Hypodermic Syringe Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 PharmaJet Needle-free Hypodermic Syringe Product Portfolio
  36. 8.6.5 PharmaJet Recent Developments
  37. 8.7 PenJet
  38. 8.7.1 PenJet Company Information
  39. 8.7.2 PenJet Business Overview
  40. 8.7.3 PenJet Needle-free Hypodermic Syringe Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 PenJet Needle-free Hypodermic Syringe Product Portfolio
  42. 8.7.5 PenJet Recent Developments
  43. 8.8 Oval Medical Technologies
  44. 8.8.1 Oval Medical Technologies Company Information
  45. 8.8.2 Oval Medical Technologies Business Overview
  46. 8.8.3 Oval Medical Technologies Needle-free Hypodermic Syringe Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Oval Medical Technologies Needle-free Hypodermic Syringe Product Portfolio
  48. 8.8.5 Oval Medical Technologies Recent Developments
  49. 8.9 Lifecare AS
  50. 8.9.1 Lifecare AS Company Information
  51. 8.9.2 Lifecare AS Business Overview
  52. 8.9.3 Lifecare AS Needle-free Hypodermic Syringe Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lifecare AS Needle-free Hypodermic Syringe Product Portfolio
  54. 8.9.5 Lifecare AS Recent Developments
  55. 8.10 Enable Injections
  56. 8.10.1 Enable Injections Company Information
  57. 8.10.2 Enable Injections Business Overview
  58. 8.10.3 Enable Injections Needle-free Hypodermic Syringe Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Enable Injections Needle-free Hypodermic Syringe Product Portfolio
  60. 8.10.5 Enable Injections Recent Developments
  61. 8.11 Crossject
  62. 8.11.1 Crossject Company Information
  63. 8.11.2 Crossject Business Overview
  64. 8.11.3 Crossject Needle-free Hypodermic Syringe Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Crossject Needle-free Hypodermic Syringe Product Portfolio
  66. 8.11.5 Crossject Recent Developments
  67. 8.12 Antares Pharma
  68. 8.12.1 Antares Pharma Company Information
  69. 8.12.2 Antares Pharma Business Overview
  70. 8.12.3 Antares Pharma Needle-free Hypodermic Syringe Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Antares Pharma Needle-free Hypodermic Syringe Product Portfolio
  72. 8.12.5 Antares Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Needle-free Hypodermic Syringe Value Chain Analysis
  2. 9.1.1 Needle-free Hypodermic Syringe Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Needle-free Hypodermic Syringe Sales Mode & Process
  6. 9.2 Needle-free Hypodermic Syringe Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Needle-free Hypodermic Syringe Distributors
  9. 9.2.3 Needle-free Hypodermic Syringe Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst